title: Management of myocardial ischemia. Is ranolazine needed? For all or some patients with myocardial ischemia?
abstract: This editorial refers to 'Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal' by U Thadani also published in this issue.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Cocco
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D006801:Humans; D017202:Myocardial Ischemia / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D000069458:Ranolazine; D026941:Sodium Channel Blockers / Q000627:therapeutic use*
chemical_list: D000083:Acetanilides; D002316:Cardiotonic Agents; D010879:Piperazines; D026941:Sodium Channel Blockers; D000069458:Ranolazine